Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 30.4B | 33.7B | 35.5B | 38.1B |
Cost of revenue | 28.5B | 31.6B | 32.7B | 35.1B |
Gross profit | 2.0B | 2.1B | 2.8B | 3.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 519M | 511M | 1.2B | 552M |
Other operating expenses | 1.6B | 1.6B | 1.5B | 1.4B |
Operating income | -395M | -42M | 45M | 996M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 233M | 233M | 237M | 241M |
Other income expense | 1.3B | 104M | 605M | 556M |
Pretax income | 648M | -13M | 413M | 1.3B |
Tax provision | 122M | -38M | 44M | 291M |
Net income | 526M | 25M | 369M | 1.0B |
Basic EPS | 1.2 | 0.0 | 0.8 | 2.4 |
Diluted EPS | 1.2 | 0.0 | 0.8 | 2.4 |
Basic average shares | 409.2M | 411.7M | 417.3M | 422.9M |
Diluted average shares | 410.5M | 413.0M | 418.8M | 425.7M |
EBITDA | 605M | 948M | 1.2B | 2.0B |
Net income from continuing op. | 526M | 25M | 369M | 1.0B |
Minority interests | -39M | -17M | -23M | -5M |
Preferred stock dividends | 2M | 2M | 3M | 3M |